Archives

For more information about Jenni, please see: https://www.linkedin.com/in/jennifer-witte-863a74257/

For more information about Sean, see his LinkedIn profile: https://www.linkedin.com/in/sean-morris-0b6a1a7/

Emily Holliday is the Vice President of Human Resources at Artio Medical. She is a seasoned executive with over 20 years of Human Resources (HR) experience. Emily is a proactive and strategic leader with experience developing and implementing polices and processes that minimize risk and ensure a positive, diverse, and ethical workplace. She joined Artio from Trystar, where she led the HR team and managed talent acquisition, employee engagement, compensation

Irina Galkina is the Controller at Artio Medical. Prior to Artio, Irina was at Aratana Therapeutics, Inc. a publicly-traded animal health company, where she held roles of increasing responsibility in finance and accounting, from Accounting Manager to Controller. As Controller at Aratana, Irina was instrumental in the acquisition of Aratana by Elanco Animal Health, Inc. in 2019.  While at Elanco Irina focused on preparation for acquisition and subsequent integration of

Mimi Fitterer is Senior Director of Technology at Artio Medical. Mimi has over 20 years of experience in medical device design, development, and process transfer. Mimi has experience leading product development efforts of new products at every stage from design concept through commercialization. Mimi was most recently at Intuitive Surgical, where she was responsible for exploring new areas for robotic surgical assistance in the endoluminal space. Prior to Intuitive Surgical,

Erdie De Peralta is Vice President of Clinical and Regulatory Affairs at Artio Medical. He is an experienced medical device professional with nearly 20 years of expertise in clinical and regulatory affairs, product development, and field and sales training. Previously, Erdie was the Vice President of Regulatory and Clinical Affairs at ExThera Medical Corporation, where he led the company in the development and execution of regulatory and clinical strategies, including

Delane Dale is Senior Director of Quality Assurance at Artio Medical. Delane has 30 plus years of medical device experience with various roles in quality assurance, quality engineering, and regulatory affairs. Delane was most recently with Confluent Medical Technologies where she was responsible for product development and sustaining quality engineering for the manufacture of neurovascular, endovascular, and cardiovascular products, including nitinol implants and catheter assemblies. Delane held similar roles with

Paul Muller is Chief Technology Officer and General Manager at Artio Medical. He is an experienced leader with over 30 years of success developing cardiovascular, peripheral vascular, and neurovascular medical devices. Prior to Artio, Paul was Chief Technology Officer and General Manager at Flow Forward Medical (acquired by Artio) where he led the product development team and moved the Arteriovenous Fistula Eligibility System program to clinical readiness. Prior to Flow

William Whitaker is a co-founder of Artio Medical and previously co-founded Flow Forward Medical, Novita Therapeutics, and Proteon Therapeutics (PRTO) where he served as Vice President, General Counsel, and Director. He helped raise more than $120 million in capital and grants for the various companies. Prior to this, Whitaker was a Partner at two law firms before forming his own practice. He had a diverse career practicing in such areas

Nicholas Franano, MD, is a physician, scientist, inventor, and entrepreneur. He is President and CEO of Artio Medical, and a co-founder. Dr. Franano is an experienced entrepreneur, founding several companies including Artio Medical, Flow Forward Medical, Novita Therapeutics, and Proteon Therapeutics (NYSE: PRTO). Dr. Franano has held positions of President, CEO, and CSO at these companies, which have raised collectively over $120 million in capital and grants. Before Proteon, Dr.